Company: ANIX
Filing Date: 2025-09-10
Form Type: 10-Q
Source: 0001493152-25-013000
Chunk: 51

Company: Anixa Biosciences Inc
Filing Date: 2025-09-10
Form: 10-Q
Item: Part I, Item 8
Chunk 51
---
960  
     5.0  
    $3.19 
  
    $
    4.02
    - $5.30  
     5,837,215  
     6.7  
    $4.20  
     3,503,275  
     6.6  
    $4.25 

Employee
Stock Purchase Plan

The
Company maintains the Anixa Biosciences, Inc. Employee Stock Purchase Plan (the “ESPP”) which permits eligible employees
to purchase shares at not less than 85% of the market value of the Company’s common stock on the offering date or the purchase
date of the applicable semi-annual offering period, whichever is lower. The ESPP was adopted by our Board of Directors on August 13,
2018 and approved by our shareholders on September 27, 2018. During the nine months ended July 31, 2025 and 2024, employees purchased
1,518 shares and 2,616 shares, respectively, under the ESPP with aggregate proceeds of approximately $4,000 and $7,000, respectively
.

Warrants

As
of July 31, 2025, we had warrants outstanding to purchase 300,000 shares of common stock at $6.56 per share, issued during fiscal year
2021 and expiring on March 22, 2026.

Information
regarding the Company’s warrants for the nine months ended July 31, 2025 is as follows:

 SCHEDULE OF WARRANTS ACTIVITY

    Shares  
    Weighted
    Average Exercise Price Per Share  
    Aggregate
     Intrinsic  Value 
  
    Warrants
    outstanding at October 31, 2024 
     300,000  
    $6.56  

    Warrants
    outstanding and exercisable at July 31, 2025 
     300,000  
    $6.56  
    $0 

    12

The
following table summarizes information about the Company’s outstanding and exercisable warrants as of July 31, 2025:

 SCHEDULE OF OUTSTANDING AND EXERCISABLE WARRANTS

    Range
    of  Exercise Prices  
    Number
     Outstanding and  Exercisable  
    Weighted
    Average  Remaining  Contractual Life  (in years)  
    Weighted
     Average